Exercise improves quality of life for patients with bone metastases
the ONA take:
According to new findings presented at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting in Melbourne, Australia, resistance training and aerobic exercise programs specifically designed to avoid injuring fragile areas of bone metastases are safe and more effective than avoiding physical activity for patients with cancer and bone metastases.
Researchers at the Edith Cowan University Health and Wellness Institute in Perth, Australia, investigated the effects of an individualized exercise program for patients with breast and prostate cancer who have metastases in the bone. The exercise programs maintained training to the body while avoiding the fragile bone sites caused by metastases.
Results showed that patients in the intervention group had improved neuromuscular strength, aerobic fitness, walking speed, physical activity, and muscle mass with no increases in bone pain or adverse events.
Most patients with cancer are often advised to exercise, but patients with skeletal metastases are the exception. The findings suggest that remaining active while avoiding fragile areas can improve quality of life without increasing the number of adverse events.
The authors note that patients with cancer who have bone metastases who are treated with this exercise intervention should be monitored closely by an exercise physiologist.
Resistance training programs designed to avoid injuring fragile areas of bone metastases are safe.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|